BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 15736971)

  • 1. The factor IXa heparin-binding exosite is a cofactor interactive site: mechanism for antithrombin-independent inhibition of intrinsic tenase by heparin.
    Yuan QP; Walke EN; Sheehan JP
    Biochemistry; 2005 Mar; 44(9):3615-25. PubMed ID: 15736971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depolymerized holothurian glycosaminoglycan and heparin inhibit the intrinsic tenase complex by a common antithrombin-independent mechanism.
    Sheehan JP; Walke EN
    Blood; 2006 May; 107(10):3876-82. PubMed ID: 16672689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The heparin-binding exosite is critical to allosteric activation of factor IXa in the intrinsic tenase complex: the role of arginine 165 and factor X.
    Misenheimer TM; Buyue Y; Sheehan JP
    Biochemistry; 2007 Jul; 46(26):7886-95. PubMed ID: 17563121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin inhibits the intrinsic tenase complex by interacting with an exosite on factor IXa.
    Sheehan JP; Kobbervig CE; Kirkpatrick HM
    Biochemistry; 2003 Sep; 42(38):11316-25. PubMed ID: 14503882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The regulation of factor IXa by supersulfated low molecular weight heparin.
    Misenheimer TM; Sheehan JP
    Biochemistry; 2010 Nov; 49(46):9997-10005. PubMed ID: 20945941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fucosylated chondroitin sulfate inhibits plasma thrombin generation via targeting of the factor IXa heparin-binding exosite.
    Buyue Y; Sheehan JP
    Blood; 2009 Oct; 114(14):3092-100. PubMed ID: 19414859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorothioate oligonucleotides inhibit the intrinsic tenase complex by an allosteric mechanism.
    Sheehan JP; Phan TM
    Biochemistry; 2001 Apr; 40(16):4980-9. PubMed ID: 11305914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of Factor X activation by the membrane-bound complex of Factor IXa and Factor VIIIa.
    Panteleev MA; Saenko EL; Ananyeva NM; Ataullakhanov FI
    Biochem J; 2004 Aug; 381(Pt 3):779-94. PubMed ID: 15104540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of sodium ion binding on factor IXa activity.
    Gopalakrishna K; Rezaie AR
    Thromb Haemost; 2006 Jun; 95(6):936-41. PubMed ID: 16732371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The factor VIIIa C2 domain (residues 2228-2240) interacts with the factor IXa Gla domain in the factor Xase complex.
    Soeda T; Nogami K; Nishiya K; Takeyama M; Ogiwara K; Sakata Y; Yoshioka A; Shima M
    J Biol Chem; 2009 Feb; 284(6):3379-88. PubMed ID: 19047063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypersulfated low molecular weight heparin with reduced affinity for antithrombin acts as an anticoagulant by inhibiting intrinsic tenase and prothrombinase.
    Anderson JA; Fredenburgh JC; Stafford AR; Guo YS; Hirsh J; Ghazarossian V; Weitz JI
    J Biol Chem; 2001 Mar; 276(13):9755-61. PubMed ID: 11134031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of factor IXa with factor VIIIa. Effects of protease domain Ca2+ binding site, proteolysis in the autolysis loop, phospholipid, and factor X.
    Mathur A; Zhong D; Sabharwal AK; Smith KJ; Bajaj SP
    J Biol Chem; 1997 Sep; 272(37):23418-26. PubMed ID: 9287357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of the NH2-terminal EGF-domain of factor IXa to the specificity of intrinsic tenase.
    Qureshi SH; Yang L; Rezaie AR
    Thromb Haemost; 2012 Dec; 108(6):1154-64. PubMed ID: 23014580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Glu113Ala mutation within a factor VIII Ca2+-binding site enhances cofactor interactions in factor Xase.
    Wakabayashi H; Su YC; Ahmad SS; Walsh PN; Fay PJ
    Biochemistry; 2005 Aug; 44(30):10298-304. PubMed ID: 16042406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Gla domain of factor IXa binds to factor VIIIa in the tenase complex.
    Blostein MD; Furie BC; Rajotte I; Furie B
    J Biol Chem; 2003 Aug; 278(33):31297-302. PubMed ID: 12782629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein S down-regulates factor Xase activity independent of activated protein C: specific binding of factor VIII(a) to protein S inhibits interactions with factor IXa.
    Takeyama M; Nogami K; Saenko EL; Soeda T; Nishiya K; Ogiwara K; Yoshioka A; Shima M
    Br J Haematol; 2008 Nov; 143(3):409-20. PubMed ID: 18759761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor VIIIa A2 subunit shows a high affinity interaction with factor IXa: contribution of A2 subunit residues 707-714 to the interaction with factor IXa.
    Griffiths AE; Rydkin I; Fay PJ
    J Biol Chem; 2013 May; 288(21):15057-64. PubMed ID: 23580639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The heparin-binding exosite of factor IXa is a critical regulator of plasma thrombin generation and venous thrombosis.
    Buyue Y; Whinna HC; Sheehan JP
    Blood; 2008 Oct; 112(8):3234-41. PubMed ID: 18647957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low molecular weight heparin inhibits plasma thrombin generation via direct targeting of factor IXa: contribution of the serpin-independent mechanism.
    Buyue Y; Misenheimer TM; Sheehan JP
    J Thromb Haemost; 2012 Oct; 10(10):2086-98. PubMed ID: 22905983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Na+ site in blood coagulation factor IXa: effect on catalysis and factor VIIIa binding.
    Schmidt AE; Stewart JE; Mathur A; Krishnaswamy S; Bajaj SP
    J Mol Biol; 2005 Jul; 350(1):78-91. PubMed ID: 15913649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.